Latest news
DPP1 Inhibition in Bronchiectasis: Mechanism and Pivotal Trial Data - HCPLiveHCPLive · Fri, 07 Aug 2026 13:06:06 GMTBronchiectasis Progression: Long-Term Consequences and Quality of Life - HCPLiveHCPLive · Fri, 07 Aug 2026 12:36:05 GMTThe Vicious Vortex: Inflammation's Role in Bronchiectasis - HCPLiveHCPLive · Fri, 07 Aug 2026 12:21:05 GMTRevagenix Doses First Participant in Phase 1 Trial of Rev-56, an Inhaled Therapy for Non-CF Bronchiectasis - GlobeNewswireGlobeNewswire · Mon, 27 Jul 2026 13:02:00 GMT